ATE203244T1 - Dreikernige kationische platinkomplexe mit antitumor wirkung, und diese enthaltende arzneizusammensetzungen - Google Patents

Dreikernige kationische platinkomplexe mit antitumor wirkung, und diese enthaltende arzneizusammensetzungen

Info

Publication number
ATE203244T1
ATE203244T1 AT95937069T AT95937069T ATE203244T1 AT E203244 T1 ATE203244 T1 AT E203244T1 AT 95937069 T AT95937069 T AT 95937069T AT 95937069 T AT95937069 T AT 95937069T AT E203244 T1 ATE203244 T1 AT E203244T1
Authority
AT
Austria
Prior art keywords
compositions containing
pct
platinum complexes
antitumor effect
containing same
Prior art date
Application number
AT95937069T
Other languages
English (en)
Inventor
Mariella Valsecchi
Paolo Pavesi
Carlo Bugatti
Ernesto Menta
Fernando C Giuliani
Carla Manzotti
Silvano Spinelli
Nicholas Virginia Comm Farrell
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE203244T1 publication Critical patent/ATE203244T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95937069T 1994-11-24 1995-11-13 Dreikernige kationische platinkomplexe mit antitumor wirkung, und diese enthaltende arzneizusammensetzungen ATE203244T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI942383A IT1271089B (it) 1994-11-24 1994-11-24 Platino complessi cationici trinucleari ad attivita' antitumorale
PCT/EP1995/004455 WO1996016068A1 (en) 1994-11-24 1995-11-13 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ATE203244T1 true ATE203244T1 (de) 2001-08-15

Family

ID=11369905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937069T ATE203244T1 (de) 1994-11-24 1995-11-13 Dreikernige kationische platinkomplexe mit antitumor wirkung, und diese enthaltende arzneizusammensetzungen

Country Status (14)

Country Link
US (1) US6011166A (de)
EP (1) EP0793667B1 (de)
JP (1) JPH10509159A (de)
AT (1) ATE203244T1 (de)
AU (1) AU3928695A (de)
CA (1) CA2205868C (de)
DE (1) DE69521810T2 (de)
DK (1) DK0793667T3 (de)
ES (1) ES2161913T3 (de)
GR (1) GR3036926T3 (de)
IT (1) IT1271089B (de)
PT (1) PT793667E (de)
WO (1) WO1996016068A1 (de)
ZA (1) ZA959986B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1292481B1 (it) * 1997-07-04 1999-02-08 Boehringer Mannheim Italia Platino complessi cationici tetra- e penta-nucleari ad attivita' antitumorale
WO2004006859A2 (en) 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
US6963002B2 (en) 2003-07-04 2005-11-08 Glenmark Pharmaceuticals Limited Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman
CA2560059A1 (en) * 2004-03-15 2005-09-29 Sonus Pharmaceuticals, Inc. Platinum carboxylate anticancer compounds
CA2560900A1 (en) * 2004-03-26 2005-10-06 Cell Therapeutics Europe S.R.L. Nanoparticle formulations of platinum compounds
EP2243773B1 (de) 2008-01-16 2013-08-14 Tenshindo Pharmaceutical Co., Ltd. Platinkomplexverbindung und deren verwendung
CN102516315B (zh) * 2011-12-12 2014-12-10 中山大学 一种具有y型结构的三核铂配合物及其对人胃腺癌细胞的靶向性

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380897A (en) * 1993-05-25 1995-01-10 Hoeschele; James D. Tri(platinum) complexes
IT1273391B (it) * 1994-03-31 1997-07-08 Boehringer Mannheim Italia Platino complessi cationici trinucleari ad attivita' antitumorale e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
AU3928695A (en) 1996-06-17
CA2205868A1 (en) 1996-05-30
ITMI942383A1 (it) 1996-05-24
IT1271089B (it) 1997-05-26
DK0793667T3 (da) 2001-10-22
ZA959986B (en) 1996-06-10
PT793667E (pt) 2001-12-28
CA2205868C (en) 2007-03-20
US6011166A (en) 2000-01-04
WO1996016068A1 (en) 1996-05-30
ITMI942383A0 (it) 1994-11-24
DE69521810D1 (de) 2001-08-23
EP0793667B1 (de) 2001-07-18
ES2161913T3 (es) 2001-12-16
GR3036926T3 (en) 2002-01-31
DE69521810T2 (de) 2002-04-04
JPH10509159A (ja) 1998-09-08
EP0793667A1 (de) 1997-09-10

Similar Documents

Publication Publication Date Title
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
MX9605665A (es) Bis (resorcinil) triazinas.
DE69634045D1 (de) Antithrombotische diamine
RU94043772A (ru) Пропинил-диароматические соединения, фармацевтические и косметические составы на их основе
BG101118A (en) Therapeutical compounds
MXPA04000577A (es) Derivados de dolastatina 10.
ATE212547T1 (de) Arzneizubereitungen enthaltend mikronisiertes nebivolol
FR2721608B1 (fr) Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
ES2144054T3 (es) Complejos de tri(platino).
ATE203244T1 (de) Dreikernige kationische platinkomplexe mit antitumor wirkung, und diese enthaltende arzneizusammensetzungen
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
DE69507694D1 (de) Trinukleare kationische platinkomplexe mit antitumor wirkung sowie diese enthaltende pharmazeutische zusammensetzungen
DE69526726D1 (de) Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
NO20010940L (no) TAN-1057 derivater
PT728138E (pt) Derivados de antraciclina
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
YU4497A (sh) Novi heteroaril - oksazolidinoni
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
FR2721314B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee